Ginkgo Bioworks Announces Date of Second Quarter 2025 Results Presentation
Ginkgo Bioworks (NYSE: DNA), a leader in cell programming and biosecurity, has scheduled its Q2 2025 earnings presentation for Thursday, August 7, 2025, at 5:30 p.m. ET. The company will review its business performance for the quarter ended June 30, 2025.
Investors can access the presentation and Q&A session through Ginkgo's investor relations website. Questions can be submitted in advance via X (using #GinkgoResults) or email to [email protected].
Ginkgo Bioworks (NYSE: DNA), leader nella programmazione cellulare e nella biosicurezza, ha programmato la sua presentazione dei risultati del secondo trimestre 2025 per gioved矛 7 agosto 2025 alle 17:30 ET. La societ脿 analizzer脿 le performance aziendali relative al trimestre conclusosi il 30 giugno 2025.
Gli investitori potranno seguire la presentazione e la sessione di domande e risposte tramite il sito web delle relazioni con gli investitori di Ginkgo. Le domande possono essere inviate in anticipo tramite X (usando l'hashtag #GinkgoResults) o via email a [email protected].
Ginkgo Bioworks (NYSE: DNA), l铆der en programaci贸n celular y bioseguridad, ha programado su presentaci贸n de resultados del segundo trimestre de 2025 para el jueves 7 de agosto de 2025 a las 5:30 p.m. ET. La empresa revisar谩 su desempe帽o comercial correspondiente al trimestre finalizado el 30 de junio de 2025.
Los inversores podr谩n acceder a la presentaci贸n y a la sesi贸n de preguntas y respuestas a trav茅s del sitio web de relaciones con inversores de Ginkgo. Las preguntas pueden enviarse con anticipaci贸n v铆a X (usando #GinkgoResults) o por correo electr贸nico a [email protected].
Ginkgo Bioworks (NYSE: DNA)電� 靹疙彫 頂勲攴鸽灅氚嶊臣 靸濍 氤挫晥 攵勳暭鞚� 靹犽憪欤检瀽搿滌劀 2025雲� 2攵勱赴 鞁れ爜 氚滍憸毳� 2025雲� 8鞗� 7鞚� 氇╈殧鞚� 鞓ろ泟 5鞁� 30攵�(霃欕秬鞁滉皠)鞐� 鞓堨爼頃橁碃 鞛堨姷雼堧嫟. 須岇偓電� 2025雲� 6鞗� 30鞚茧 膦呺霅� 攵勱赴鞚� 靷梾 鞁れ爜鞚� 瓴�韱犿暊 鞓堨爼鞛呺媹雼�.
韴瀽鞛愲摛鞚� Ginkgo鞚� 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼毳� 韱淀暣 氚滍憸 氚� 歆堨潣鞚戨嫷 靹胳厴鞐� 彀胳棳頃� 靾� 鞛堨姷雼堧嫟. 歆堧鞚� 靷爠鞐� X(頃挫嫓韮滉犯 #GinkgoResults 靷毄) 霕愲姅 鞚措⿺鞚� [email protected]鞙茧 鞝滌稖頃� 靾� 鞛堨姷雼堧嫟.
Ginkgo Bioworks (NYSE : DNA), leader en programmation cellulaire et bios茅curit茅, a programm茅 sa pr茅sentation des r茅sultats du deuxi猫me trimestre 2025 pour le jeudi 7 ao没t 2025 脿 17h30 (heure de l鈥橢st). La soci茅t茅 pr茅sentera ses performances commerciales pour le trimestre clos au 30 juin 2025.
Les investisseurs pourront acc茅der 脿 la pr茅sentation ainsi qu鈥櫭� la s茅ance de questions-r茅ponses via le site des relations investisseurs de Ginkgo. Les questions peuvent 锚tre soumises 脿 l鈥檃vance via X (en utilisant le hashtag #GinkgoResults) ou par email 脿 [email protected].
Ginkgo Bioworks (NYSE: DNA), ein f眉hrendes Unternehmen im Bereich Zellprogrammierung und Biosicherheit, hat seine Ergebnispr盲sentation f眉r das zweite Quartal 2025 f眉r Donnerstag, den 7. August 2025, um 17:30 Uhr ET angesetzt. Das Unternehmen wird die Gesch盲ftsergebnisse f眉r das Quartal zum 30. Juni 2025 vorstellen.
Investoren k枚nnen die Pr盲sentation und die Fragerunde 眉ber die Investor-Relations-Website von Ginkgo verfolgen. Fragen k枚nnen im Voraus 眉ber X (mit dem Hashtag #GinkgoResults) oder per E-Mail an [email protected] eingereicht werden.
- None.
- None.
Presentation and Q&A session scheduled for post-market on Thursday, August 7, 2025
The presentation details and webcast link will be available on Ginkgo's investor relations website at , and a replay will be made available.
To ask a question ahead of the presentation, please submit them to @ on X (hashtag #GinkgoResults) or by sending an e-mail to [email protected].
About Ginkgo Bioworks
Ginkgo Bioworks builds the tools that make biology easier to engineer for everyone. Ginkgo R&D Solutions delivers customizable R&D packages鈥攕uch as protein engineering, nucleic acid design, and cell-free systems鈥攇iving partners a comprehensive way to accelerate innovation across therapeutics, diagnostics, & manufacturing. Ginkgo Automation sells modular, integrated laboratory automation so scientists can spend their days planning and analyzing experiments rather than pipetting in the lab. Ginkgo Datapoints uses Ginkgo's in-house automation to generate the large lab data sets to power your AI models. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats. For more information, visit and , read our , or follow us on social media channels such as X (@ and @), Instagram (@), Threads (@), or .
Ginkgo Bioworks Contacts:
INVESTOR CONTACT:
MEDIA CONTACT:
View original content to download multimedia:
SOURCE Ginkgo Bioworks
FAQ
When is Ginkgo Bioworks (DNA) reporting Q2 2025 earnings?
How can investors access Ginkgo Bioworks' Q2 2025 earnings call?
How can investors submit questions for Ginkgo Bioworks' Q2 2025 earnings call?
What period will Ginkgo Bioworks' Q2 2025 results cover?
